![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 18, 17725-17731, May 6, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
||
**
**



From the
Departments of
Biochemistry and Molecular Pharmacology,
Neurology, and 
Cell Biology and the **Neuroscience Program, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron degeneration, paralysis, and death. Mutant Cu,Zn-superoxide dismutase (SOD1) causes a subset of ALS by an unidentified toxic property. Increasing evidence suggests that chaperone dysfunction plays a role in motor neuron degeneration in ALS. To investigate the relationship between mutant SOD1 expression and chaperone dysfunction, we measured chaperone function in central nervous system tissue lysates from normal mice and transgenic mice expressing human SOD1 variants. We observed a significant decrease in chaperone activity in tissues from mice expressing ALS-linked mutant SOD1 but not control mice expressing human wild type SOD1. This decrease was detected only in the spinal cord, became apparent by 60 days of age (before the onset of muscle weakness and significant motor neuron loss), and persisted throughout the late stages. In addition, this impairment of chaperone activity occurred only in cytosolic but not in mitochondrial and nuclear fractions. Furthermore, multiple recombinant human SOD1 mutants with differing biochemical and biophysical properties inhibited chaperone function in a cell-free extract of normal mouse spinal cords. Thus, mutant SOD1 proteins may impair chaperone function independent of gene expression in vivo, and this inhibition may be a shared property of ALS-linked mutant SOD1 proteins.
Received for publication, February 14, 2005
* This work was supported by NINDS, National Institutes of Health Grant RO1 NS41739, the Amyotrophic Lateral Sclerosis (ALS) Association, and The Robert Packard Center for ALS Research at Johns Hopkins (to Z. X.), and NINDS, National Institutes of Health Grant R01 NS44170, the ALS Association, and the Muscular Dystrophy Association (to L. J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1S4.
¶ Supported by an ALS Association fellowship.
|| Supported by a National Institutes of Health post-doctoral fellowship.

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 01605. Tel.: 508-856-3309; Fax: 508-856-2003; E-mail: zuoshang.xu{at}umassmed.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Basso, T. Massignan, G. Samengo, C. Cheroni, S. De Biasi, M. Salmona, C. Bendotti, and V. Bonetto Insoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis Mice J. Biol. Chem., November 3, 2006; 281(44): 33325 - 33335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tiwari, Z. Xu, and L. J. Hayward Aberrantly Increased Hydrophobicity Shared by Mutants of Cu,Zn-Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., August 19, 2005; 280(33): 29771 - 29779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, G. Xu, H. Li, V. Gonzales, D. Fromholt, C. Karch, N. G. Copeland, N. A. Jenkins, and D. R. Borchelt Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {alpha}B-crystallin modulates aggregation Hum. Mol. Genet., August 15, 2005; 14(16): 2335 - 2347. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |